Evanson Jeff 4
4 · Outlook Therapeutics, Inc. · Filed Apr 19, 2023
Insider Transaction Report
Form 4
Evanson Jeff
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-04-17+192,143→ 192,143 totalExercise: $1.08Exp: 2033-04-17→ Common Stock (192,143 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest on April 17, 2024, with the remaining shares vesting in equal monthly installments over the following three years thereafter, subject to the Reporting Person's continuous service with the Issuer on each such date. The option is also subject to acceleration under certain circumstances.